Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

ContextVision – Aiming to build the company’s first modern pathology lab

Published

on

STOCKHOLM – October 21, 2021 – ContextVision, a medical technology software company specializing in image processing and decision support tools within digital pathology, has decided to build its first fully digital pathology laboratory – thus confirming its strong dedication to advancing digitalization within pathology, for the best of both patients and the medical profession.

Sales in the third quarter reached 26.0 MSEK (22.0), a 7% increase compared with the previous quarter, and an increase of 18% versus last year’s corresponding quarter. EBITDA ended at 5.7 MSEK and the cash position was 48.1 MSEK at the end of the quarter.

Building our own modern digital pathology lab would enable us to advance faster and create greater value for patients, clinicians and pathologists. We have investigated this path in a research project for quite some time. The need is unquestioned, and the potential is huge, making this a game changer for ContextVision,” says CEO Fredrik Palm of ContextVision.

Lab manager already recruited
INIFY Prostate will be the core machine learning technology intended to be seamlessly integrated in the lab. Statistical process control over the entire chain, from specimen delivery to diagnostic report, will enable an innovative pathology service with the highest efficiency and diagnostic quality. The lab will focus on prostate cancer diagnosis as a start, and the first steps are already taken.

Negotiations have been initiated regarding lab premises in Stockholm in proximity to world-class medical research and healthcare. We have already recruited an experienced lab manager, a vital team member in the construction and operation of the lab, who will join us full-time in January 2022,” says Palm.

In connection with this, the board of directors has instructed the management to create a subsidiary for the intended laboratory operations.

INIFY development
Results from the company’s multicenter study in EU were presented at the European Congress of Pathology in August. The study showed that INIFY Prostate is robust across the four different sites involved, and that the pathologists and surrounding staff were very positive to the product’s performance.

Recently announced, first results from the ongoing studies in the United States were presented at the Pathology Vision congress in Las Vegas. These showed an impressive sensitivity in detecting cancer areas, including very small areas of ≤1mm. The study was conducted with two labs to prove the robustness against differences in hardware setups.

Additionally, results from an ongoing research project in Sweden within colorectal cancer were presented. They indicated that the pathologist could perform assessments significantly faster with maintained diagnostic accuracy, when using our prototype.

Strong sales
Medical Imaging business continues on its positive path. At long last, the world is gradually reopening, enabling staff to travel and meet present and new potential customers. Exceptional orders in America took the company to a third quarter sales record. Sales in America are expected to grow in comparison with historical numbers, but will most likely become more evenly distributed during the upcoming year.

Strong sales continue to give signals of a stepwise return to our expected pre-pandemic growth plan. With important organization additions strengthening our team, we look forward to the fourth quarter and a strong year finish, while preparing for a successful 2022,” says Palm.

The company will hold a presentation and Q&A web conference on Oct 22nd at 09:30-10:15 CEST – use the link below for registration.
https://attendee.gotowebinar.com/register/2010501410324446735

###

For further information, please contact ContextVision’s CEO, Fredrik Palm, at [email protected], or visit www.contextvision.com

###

About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X- ray and MRI equipment around the world.

Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.

ContextVision has built up a business unit for the fast-growing digital pathology market. We are re-investing significantly in our product portfolio of decision support tools, and we are dedicated to becoming a leading resource for pathologists to radically develop cancer diagnosis and improve patient care.

The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.

This information is considered to be inside information pursuant to the EU Market Abuse Regulation article 7 and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was submitted for publication, through the agency of the contact persons set out above on 21 October 2021.

Attachment

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Department of Health – Abu Dhabi Unveils ‘Declaration of Principles’ on Bioconvergence to Enhance Global Healthcare Outcomes

Published

on

department-of-health-–-abu-dhabi-unveils-‘declaration-of-principles’-on-bioconvergence-to-enhance-global-healthcare-outcomes

ABU DHABI, UAE, May 13, 2024 /PRNewswire/ — An an outcome of the Health Leaders Forum (HLF) organised during Abu Dhabi Global Healthcare Week (ADGHW), the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, unveiled a Declaration of Principles on Bioconvergence, to transform healthcare, improve human health and well-being. As a first-of-its-kind initiative, the Declaration outlines global principles covering guidance on transparency, accountability, and bias mitigation, as well as research ethics and ethical decision-making in the field of Bioconvergence.

Bioconvergence has been recognised as the latest technological trend of the 21st century for the healthcare sector. It is a transdisciplinary field that merges engineering and life sciences, and is set to revolutionise the health-tech industry. Bioconvergence fuses life sciences with a vast number of technologies from fields such as mathematics, engineering, and physical and computational sciences.
The Declaration of Principles will witness leading local and global entities collaborate with DoH including Amazon, Microsoft, UAE University (UAEU), Mohammad Bin Zayed University for AI (MBZUAI), Core 42 and Masdar City. Segmented into six strategic pillars, the principles aim to advance Bioconvergence research and development, encourage investment in the field to address urgent healthcare challenges, establish international cooperation frameworks, prioritise research areas in public health and personalised medicine, and promote the adoption of advanced technologies such as Artificial Intelligence (AI) and nanomedicine.
Dr. Asma Ibrahim Al Mannaei, the Executive Director of the Research and Innovation Centre at the Department of Health – Abu Dhabi (DoH): “In the intricacies of Bioconvergence, establishing fundamental principles is not merely a choice, but a collective responsibility. These principles serve as a beacon of transparency, guardians of accountability and shields against any form of bias. With the ever-evolving intersection of health and technology, integrity and diligence remain guiding threads for the Department of Health – Abu Dhabi. Reinforcing Abu Dhabi’s position as a leading destination for innovation in healthcare, the unique Declaration serves as a testament to the Department’s continued efforts to build a healthier world and shape the future of healthcare for generations to come.”
Moreover, upholding ethical standards and responsible practices involve raising awareness on the benefits and risks of Bioconvergence technologies, establishing ethical guidelines, and ensuring accessibility and affordability for all. Investment in education and workforce development entails supporting skill development, integrating Bioconvergence into relevant curricula, fostering interdisciplinary collaboration, and promoting diversity in the field.
Additionally, fostering collaboration and the exchange of knowledge among stakeholders, advocating for supportive policies and regulations, and engaging the community through awareness campaigns and transparent communication are crucial steps in advancing Bioconvergence research and innovation while maintaining community’s trust and support. These key pillars will support accelerating the future of healthcare and life sciences by making quality health a global priority.
Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, Abu Dhabi Global Healthcare Week is a major government initiative taking place between 13 and 15 May 2024. ADGHW seeks to accelerate collaboration, innovation, and investment, and bring together researchers, policymakers, healthcare specialists, investors, and entrepreneurs across the global healthcare and life science ecosystem.
For more information please visit: https://www.adghw.com/
About Department of Health – Abu Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system.
For further information on DoH, visit https://www.doh.gov.ae/ and follow on X, Instagram, Facebook, LinkedIn and YouTube.
Photo – https://mma.prnewswire.com/media/2411144/DoH_Abu_Dhabi.jpg

View original content:https://www.prnewswire.co.uk/news-releases/department-of-health–abu-dhabi-unveils-declaration-of-principles-on-bioconvergence-to-enhance-global-healthcare-outcomes-302143829.html

Continue Reading

Artificial Intelligence

Advanced HPC Server Platforms by MiTAC and TYAN Spotlighted at ISC High Performance 2024

Published

on

advanced-hpc-server-platforms-by-mitac-and-tyan-spotlighted-at-isc-high-performance-2024

HAMBURG, Germany, May 13, 2024 /PRNewswire/ — Today, the subsidiary of MiTAC Holdings Corp.(TSE:3706), MiTAC Computing Technology and its server brand TYAN®, the leading manufacturer in server platform design worldwide, bring their new server platforms to the ISC 2024 event, booth #B01 in Hamburg, Germany. These solutions harness the power of the latest AMD EPYC 9004 series and AMD Ryzen 7000 series, along with the 5th Gen Intel Xeon Scalable Processors, offering optimized performance for HPC needs.

MiTAC introduces its revolutionary lineup of DSG products
Driven by shared values, MiTAC and Intel have had a strong partnership for years. Last year, MiTAC took over the manufacturing and sales of products designed by Intel Datacenter Solution Group (DSG). Today, MiTAC presents two models from its DSG product lineups, which are from the Intel Server M50FCP Family and the Intel Server D50DNP Family, at ISC 2024.
First, MiTAC displays a multi-node server, the Intel Server System D50DNP1MHEVAC 1U Half-Width air-cooled compute module with EVAC heatsink from the Intel Server D50DNP Family (Denali Pass). Intel® Server D50DNP family is the highest-performance density server featuring 5th/4th Gen Intel® Xeon® Scalable Processors or the Intel® Xeon® CPU Max Series and purpose-built modules, delivering robust performance, efficiency, and scalability tailored to specific needs for AI computing.
Then, there is the 1U Intel Server System M50FCP1UR204 from the Intel Server M50FCP Family (Fox Creek Pass). Supporting 5th/4th Gen Intel® Xeon® Scalable processors, the general purpose Intel® Server M50FCP Family offers robust compute capabilities, integrated accelerators, and exceptional I/O and memory bandwidth, making it the perfect solution for handling data-intensive mainstream tasks.
TYAN brings HPC optimized servers at ISC 2024
The Transport CX TD76-B8058 is a 2U 4-node single-socket HCI server powered by AMD EPYC 9004 processors. Each node includes 16 DDR5-4800 DIMM slots, 4 hot-swappable E1.s drive bays, 2 NVMe M.2 slots, 1 OCP v3.0 LAN mezzanine slot, and 1 standard PCIe 5.0 x16 slot. Front I/O facilitates efficient network cable routing, while rear-accessible hot-swappable cooling fans and redundant 80+ Titanium power supplies ensure optimal system serviceability.  Powered by 5th/4th Gen Intel Xeon Scalable processor, TYAN Thunder CX TD76-B5658 is a 2U 4 nodes single-socket server designed for high-density cloud server deployment. It comes with shared system fans, redundant 80+ Titanium power supplies, and hot-swappable modules for simple maintenance. Additionally, it offers front I/O for effortless network cable management, and each node supports PCIe 5.0 x16, OCP v3.0 LAN mezzanine, and NVMe E1.s SSDs.
Apart from the above, TYAN provides the Transport CX GX40-B8016 for those requiring entry-level servers. This compact 1U AMD Ryzen cloud server is perfect for front-end portal and edge computing tasks in data centers. It features 4 DDR5-4800 UDIMM slots, supports up to 4 SATA drives, 2 NVMe M.2 slots, and one PCIe 5.0 x16 slot.
About MiTAC Computing Technology Corp.
MiTAC Computing Technology Corp, a MiTAC Holdings Corp. (TSE:3706) subsidiary, specializes in cloud and edge computing solutions and has over 30 years of design and manufacturing expertise. With a strong focus on large-scale data centers, the company offers flexible and customized supply models for various systems and applications. Its product lineup includes TYAN servers, 5G ORAN servers, high-performance AI servers, and data center products. Intel Datacenter Solutions Group (DSG) transited its business to MiTAC since July 2023, allowing MiTAC expanding its product offerings with cutting-edge total cost of ownership solutions for next-gen data center equipment.
MiTAC Computing Technology Official website: www.mitacmct.com
MiTAC DSG website: https://datacentersolutions.mitacmct.com/
About TYAN
TYAN, as a leading server brand of MiTAC Computing Technology Corporation under the MiTAC Holdings Corp. (TSE:3706), designs, manufactures and markets advanced x86 and x86-64 server/workstation board technology, platforms and server solution products. Its products are sold to OEMs, VARs, System Integrators and Resellers worldwide for a wide range of applications. TYAN enables its customers to be technology leaders by providing scalable, highly-integrated, and reliable products for a wide range of applications such as server appliances and solutions for HPC, hyper-scale/data center, server storage, AI and security appliance markets. For more information, please visit TYAN’s website at http://www.tyan.com or MiTAC Computing Technology Corporation website at http://www.mitacmct.com
AMD, the AMD Arrow logo, EPYC, Ryzen and combinations thereof are trademarks of Advanced Micro Devices, Inc.
Intel, the Intel logo, Xeon and combinations thereof are trademarks of Intel Corporation
Photo – https://mma.prnewswire.com/media/2408826/2024_ISC_PR.jpg

View original content:https://www.prnewswire.co.uk/news-releases/advanced-hpc-server-platforms-by-mitac-and-tyan-spotlighted-at-isc-high-performance-2024-302141236.html

Continue Reading

Artificial Intelligence

Department of Health – Abu Dhabi partners with MBZUAI and Core42 to launch Global AI Healthcare Academy

Published

on

department-of-health-–-abu-dhabi-partners-with-mbzuai-and-core42-to-launch-global-ai-healthcare-academy

ABU DHABI, UAE, May 13, 2024 /PRNewswire/ — The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), the leading AI research-based academic institution located in Abu Dhabi, and Core42, a G42 company offering AI solutions, during Abu Dhabi Global Healthcare Week (ADGHW). This MoU will launch the global AI Healthcare Academy to the health workforce. The MoU was signed by Dr. Rashed Obaid Al Suwaidi, Executive Director of Healthcare Workforce Planning Sector at DoH, Sultan Al Hajji, Vice President of Public Affairs and Alumni Relations at MBZUAI and Talal Al Kaissi, Executive Vice President, Chief Product and Global Partnership Officer at Core42.

 
 
Reinforcing Abu Dhabi’s position as a leading destination for healthcare and life sciences, the partnership seeks to establish a framework of collaboration to strengthen the Emirate’s position at the forefront of technology-enabled and data-driven healthcare systems. The new AI Healthcare Academy will help to build a global AI-trained workforce, which is capable of advancing diagnostic and operational efficiency, significantly improving patient care, and streamlining healthcare processes around the world.
Sultan Al Hajji, Vice President of Public Affairs and Alumni Relations at MBZUAI, said: “Healthcare is a key research pillar for MBZUAI, because we recognise the transformative and life-saving potential of AI across a wide range of diagnostic and treatment areas. In addition to our recent effort in establishing the Institute of Digital Public Health, we are proud to partner with The Department of Health – Abu Dhabi in launching the new AI Healthcare Academy. MBZUAI will provide the Academy our world-class faculty to facilitate AI workshops and training to upskill the healthcare workforce in support of the UAE leadership’s vision to become a global hub for AI and a centre for life sciences.”
Through leveraging advanced technologies and harnessing the power of AI, DoH seeks to upskill the health workforce, enhance local practices and contribute to broader medical research and treatment modalities worldwide. By embracing AI-driven technologies, healthcare professionals can stay at the forefront of innovation, fostering collaboration and knowledge exchange on a global scale.
By collaborating with MBZUAI through its Institute of Digital Public Health, the Academy will encompass ground-breaking research. These efforts will encourage public-private partnerships, fostering collaboration to secure ample funding and ensure ongoing sustainability, setting the academy for long-term success and supporting responsible and impactful innovation.
Under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council, Abu Dhabi Global Healthcare Week (ADGHW) is a major government initiative from DoH, taking place between 13 and 15 May 2024.
For more information please visit: https://www.adghw.com/
About Department of Health – Abu Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system.
For further information on DoH, visit https://www.doh.gov.ae/ and follow on X, Instagram, Facebook, LinkedIn and YouTube.
About Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)
MBZUAI is a graduate, research university focused on artificial intelligence, computer science, and digital technologies across industrial sectors. The university aims to empower students, businesses, and governments to advance artificial intelligence as a global force for positive progress. MBZUAI offers various graduate programs designed to pursue advanced, specialized knowledge and skills in artificial intelligence, including computer science, computer vision, machine learning, natural language processing, and robotics. For more information, please visit www.mbzuai.ac.ae.
Photo – https://mma.prnewswire.com/media/2411164/The_Department_of_Health_Abu_Dhabi.jpg

View original content:https://www.prnewswire.co.uk/news-releases/department-of-health–abu-dhabi-partners-with-mbzuai-and-core42-to-launch-global-ai-healthcare-academy-302143723.html

Continue Reading

Trending